Corteva, Inc. $CTVA Shares Sold by AIA Group Ltd

AIA Group Ltd trimmed its stake in shares of Corteva, Inc. (NYSE:CTVA) by 7.8% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 97,426 shares of the company’s stock after selling 8,185 shares during the period. AIA Group Ltd’s holdings in Corteva were worth $8,156,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the stock. JPL Wealth Management LLC acquired a new stake in Corteva in the 3rd quarter valued at about $25,000. Westfuller Advisors LLC increased its holdings in shares of Corteva by 2,764.3% in the first quarter. Westfuller Advisors LLC now owns 401 shares of the company’s stock valued at $34,000 after purchasing an additional 387 shares during the last quarter. Garton & Associates Financial Advisors LLC acquired a new stake in shares of Corteva in the fourth quarter valued at approximately $27,000. Bank of Jackson Hole Trust purchased a new position in Corteva during the fourth quarter worth approximately $28,000. Finally, Cornerstone Financial Management LLC purchased a new position in Corteva during the fourth quarter worth approximately $29,000. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Stock Up 0.9%

Shares of NYSE CTVA opened at $87.42 on Friday. The stock has a market cap of $58.47 billion, a P/E ratio of 51.43, a PEG ratio of 2.67 and a beta of 0.56. The company has a current ratio of 1.47, a quick ratio of 1.03 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12-month low of $60.53 and a 12-month high of $88.22. The business’s fifty day simple moving average is $80.86 and its 200-day simple moving average is $78.19.

Corteva (NYSE:CTVA) last released its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping the consensus estimate of $1.18 by $0.32. The firm had revenue of $4.91 billion during the quarter, compared to analysts’ expectations of $4.64 billion. Corteva had a return on equity of 9.95% and a net margin of 6.50%.Corteva’s revenue for the quarter was up 11.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.13 EPS. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, equities analysts predict that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, June 15th. Investors of record on Monday, June 1st were paid a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date was Monday, June 1st. Corteva’s dividend payout ratio (DPR) is currently 42.35%.

Analyst Ratings Changes

CTVA has been the subject of a number of recent research reports. Zacks Research raised Corteva from a “hold” rating to a “strong-buy” rating in a research note on Monday, July 13th. Citigroup boosted their price target on shares of Corteva from $83.00 to $85.00 and gave the company a “neutral” rating in a research report on Thursday, May 7th. Jefferies Financial Group upped their price objective on shares of Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. CICC Research raised their price objective on shares of Corteva from $80.00 to $93.00 and gave the stock an “outperform” rating in a research report on Wednesday, May 13th. Finally, UBS Group decreased their target price on shares of Corteva from $90.00 to $86.00 and set a “neutral” rating on the stock in a report on Tuesday, June 9th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat.com, Corteva has a consensus rating of “Moderate Buy” and an average price target of $88.95.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.